Advertisement

Preclinical studies of gilteritinib, a next-generation FLT3 inhibitor

Lauren Y. Lee, Daniela Hernandez, Trivikram Rajkhowa, Samuel C. Smith, Jayant Ranganathan Raman, Bao Nguyen, Donald Small and Mark Levis

Article Information

Citation 
vol. 129 no. 2 257-260
PubMed 

Print ISSN 
Online ISSN 
History 
  • Published online January 12, 2017.

Article Versions


Contributors 
  • Lauren Y. Lee, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Daniela Hernandez, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Trivikram Rajkhowa, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Samuel C. Smith, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Jayant Ranganathan Raman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Bao Nguyen, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Donald Small, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
  • Mark Levis, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output